Kevin Coker, Jd, Mph, Ms

We are an advanced biomaterials and biofabrication company.

MolecularMatch, Inc. is a Houston, Texas-based clinical informatics SaaS company founded in 2014 out of MD Anderson Cancer Center. The company was founded on the vision of using tumor molecular profiling, and outcomes from previously-treated patients, to provide the best personalized treatment for current patients. MolecularMatch delivers personalized, evidence-based therapeutic guidance and clinical trials matched to each patient. Customers include genetic labs, health information systems, biopharma, hospitals, and cancer centers.

First Bight Ventures is the first early stage fund that is dedicated to synthetic biology start-ups. We see the potential of syn-bio across broad range of verticals that could truly transform the world for a sustainable future. These verticals include (but not limited to) energy, chemical, agriculture, medicine, heavy industries and consumer goods.

M1 is a medical technology accelerator that supports early-stage medical device founders looking to rapidly progress toward commercialization. We bring together a wide network of founders, advisors, service providers, and subject matter experts to guide cohort teams during and beyond the program. Teams receive an equity investment and participate in a three-month, hands-on, practical workshop curriculum designed to drive them through company and product development in weeks instead of years. Our program focuses on providing a personal, founder-centered experience by accepting a limited number of companies into each cohort and providing ongoing tailored mentoring and coaching for each company. Additionally, our educational curriculum leans heavily on practical, interactive workshop sessions where cohort companies quickly push through milestones as they continually develop their business. Finally, M1 provides each team with specific, tailored connections vetted by our team through professional partnerships. Our team has a breadth of experience across medtech and biotech development from discovery to product launch and beyond. Together with our network of expert partners, our team educates, coaches, and supports founders in driving their devices toward commercialization. #medtech #accelerator #innovation #medicaldevice #venture #medical #technology

We are an advanced biomaterials and biofabrication company.

MolecularMatch, Inc. is a Houston, Texas-based clinical informatics SaaS company founded in 2014 out of MD Anderson Cancer Center. The company was founded on the vision of using tumor molecular profiling, and outcomes from previously-treated patients, to provide the best personalized treatment for current patients. MolecularMatch delivers personalized, evidence-based therapeutic guidance and clinical trials matched to each patient. Customers include genetic labs, health information systems, biopharma, hospitals, and cancer centers.